Return on Assets: An indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Calculated as: Income from Continuing Operations / Total Assets
Calidi Biotherapeutics, Inc. (CLDI) had Return on Assets of -42.83% for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-4.42M |
|
-- |
|
-- |
|
$4.19M |
|
$-4.19M |
|
$0.08M |
|
$-4.10M |
|
$-4.10M |
|
$-4.11M |
|
$-4.11M |
|
$-4.11M |
|
$-4.11M |
|
$-4.19M |
|
$-3.76M |
|
10.31M |
|
10.31M |
|
$-0.43 |
|
$-0.43 |
|
| Balance Sheet Financials | |
$7.35M |
|
$0.76M |
|
$2.24M |
|
$9.59M |
|
$3.84M |
|
$0.75M |
|
$0.82M |
|
$4.66M |
|
$4.93M |
|
$4.93M |
|
$4.93M |
|
11.79M |
|
| Cash Flow Statement Financials | |
$-4.12M |
|
$-0.01M |
|
$5.16M |
|
$5.82M |
|
$6.85M |
|
$1.03M |
|
$0.23M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.92 |
|
-- |
|
-- |
|
0.13 |
|
0.18 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.12M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-83.24% |
|
-83.24% |
|
|
Return on Assets |
-42.83% |
-72.30% |
|
$0.42 |
|
$-0.40 |
|
$-0.40 |
|